The CDK4/6 inhibitor PD0332991 reverses epithelial dysplasia associated with abnormal activation of the cyclin-CDK-Rb pathway

M. Carla Cabrera, Edgar S. Díaz-Cruz, Bhaskar V.S. Kallakury, Michael J. Pishvaian, Clinton J. Grubbs, Donald D. Muccio, Priscilla A. Furth

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'The CDK4/6 inhibitor PD0332991 reverses epithelial dysplasia associated with abnormal activation of the cyclin-CDK-Rb pathway'. Together they form a unique fingerprint.

Medicine & Life Sciences